United States Biotechnology & Medical Research

Generex Biotechnology Corp (GNBT)

Track

Ticker: GNBT Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 7 Dec 2018
Value US$4,339,066.48 | Price 354.68 | Shares 34,469 (-34.4%)
Buy 7 Dec 2018
Value US$923,423.77 | Price 281.36 | Shares 15,425 (-28.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-12-14 2018-12-07 B Purchase Haines Harold Gray

Consultant
34,469 -34.4%
354.68
US$4,339,066 		34,469 -34.4% 354.68 US$4,339,066
2018-12-14 2018-12-07 B Purchase Haines Harold Gray

Consultant
15,425 -28.8%
281.36
US$923,424 		15,425 -28.8% 281.36 US$923,424
2018-12-14 2018-12-04 B Purchase Haines Harold Gray

Consultant
13,703 -14.8%
96.66
US$1,087,618 		13,703 -14.8% 96.66 US$1,087,618
2018-12-14 2018-12-04 B Purchase Haines Harold Gray

Consultant
555 +inf%
2.10
US$1,166 		555 +inf% 2.10 US$1,166
2013-06-20 2013-06-18 S Sale FELLOWS STEPHEN

Chief Financial Officer

Officer
2,524,164 -100.0%
0.04
US$89,608 		2,524,164 -100.0% 0.04 US$89,608
2012-06-27 2012-06-25 S Sale FELLOWS STEPHEN

Acting Chief Financial Officer

Officer
546,448 -100.0%
0.09
US$50,383 		546,448 -100.0% 0.09 US$50,383
2011-05-11 2011-05-09 S Sale PERRI ROSE C Non-Executive Director
15,000 -1.5%
0.23
US$3,450 		15,000 -1.5% 0.23 US$3,450
2011-05-09 2011-05-06 S Sale PERRI ROSE C Non-Executive Director
20,000 -2.0%
0.23
US$4,500 		20,000 -2.0% 0.23 US$4,500
2011-05-04 2011-05-03 S Sale PERRI ROSE C Non-Executive Director
25,000 -2.4%
0.22
US$5,500 		25,000 -2.4% 0.22 US$5,500
2011-04-07 2011-04-06 B Purchase FLETCHER MARK

See Remarks

Officer
20,000 +7.5%
0.24
US$4,780 		20,000 +7.5% 0.24 US$4,780
2010-10-27 2010-10-27 B Purchase PERRI ROSE C

COO, CFO& Treas.

Executive Director
54,000 +13.3%
0.35
US$18,900 		54,000 +13.3% 0.35 US$18,900
2010-01-04 2010-01-04 B Purchase FLETCHER MARK

EVP & General Counsel

Officer
8,700 +3.4%
0.52
US$4,524 		8,700 +3.4% 0.52 US$4,524
2009-11-16 2009-11-16 B Purchase PERRI ROSE C

COO, CFO, Treas. & Secy.

Executive Director
10,000 +2.5%
0.51
US$5,100 		10,000 +2.5% 0.51 US$5,100
2009-11-16 2009-11-13 B Purchase Masterson Nola E Non-Executive Director
10,000 +20.0%
0.49
US$4,900 		10,000 +20.0% 0.49 US$4,900
2009-11-16 2009-11-13 B Purchase FLETCHER MARK

EVP & General Counsel

Officer
10,000 +4.0%
0.49
US$4,900 		10,000 +4.0% 0.49 US$4,900
2009-11-13 2009-11-12 S Sale Masterson Nola E Non-Executive Director
50,000 -50.0%
0.50
US$25,000 		50,000 -50.0% 0.50 US$25,000
2009-10-19 2009-10-19 S Sale Masterson Nola E Non-Executive Director
2,700 -2.6%
0.69
US$1,863 		2,700 -2.6% 0.69 US$1,863
2009-01-12 2009-01-12 B Purchase FLETCHER MARK

EVP & General Counsel

Officer
2,200 +0.9%
0.33
US$726 		2,200 +0.9% 0.33 US$726
2009-01-12 2009-01-12 B Purchase FLETCHER MARK

EVP & General Counsel

Officer
10,159 +4.3%
0.32
US$3,251 		10,159 +4.3% 0.32 US$3,251
2008-11-03 2008-10-31 B Purchase FLETCHER MARK

EVP & General Counsel

Officer
24,500 +11.6%
0.38
US$9,310 		24,500 +11.6% 0.38 US$9,310
2008-11-03 2008-10-31 B Purchase FLETCHER MARK

EVP & General Counsel

Officer
500 +0.2%
0.37
US$185 		500 +0.2% 0.37 US$185
2008-10-14 2008-10-13 B Purchase PERRI ROSE C

COO, CFO, Treas. & Secy.

Executive Director
3,800 +1.0%
0.31
US$1,178 		3,800 +1.0% 0.31 US$1,178
2008-10-14 2008-10-13 B Purchase PERRI ROSE C

COO, CFO, Treas. & Secy.

Executive Director
11,200 +2.9%
0.30
US$3,360 		11,200 +2.9% 0.30 US$3,360
2008-04-21 2008-04-18 S Sale FLETCHER MARK

VP & General Counsel

Officer
128,342 -37.9%
1.16
US$148,877 		128,342 -37.9% 1.16 US$148,877
2008-04-21 2008-04-18 S Sale FLETCHER MARK

VP & General Counsel

Officer
100,000 -22.8%
1.14
US$114,000 		100,000 -22.8% 1.14 US$114,000
2008-03-12 2008-03-11 B Purchase Masterson Nola E Non-Executive Director
2,700 +2.7%
1.06
US$2,862 		2,700 +2.7% 1.06 US$2,862
2006-03-28 2006-03-27 B Purchase MCGEE BRIAN Non-Executive Director
26,000 +37.1%
3.22
US$83,720 		26,000 +37.1% 3.22 US$83,720
2006-03-22 2006-03-20 B Purchase ALLPORT SETTLE MINDY J Non-Executive Director
1,550 +100.0%
3.20
US$4,960 		1,550 +100.0% 3.20 US$4,960
2006-03-22 2006-03-20 B Purchase ALLPORT SETTLE MINDY J Non-Executive Director
1,550 +inf%
3.18
US$4,929 		1,550 +inf% 3.18 US$4,929
2006-03-02 2006-02-28 B Purchase MCGEE BRIAN Non-Executive Director
70,000 +inf%
2.21
US$154,700 		70,000 +inf% 2.21 US$154,700
2004-01-23 2004-01-23 B Purchase GLUSKIN ANNA E

CEO and President

Executive Director
500 +3.1%
1.71
US$855 		500 +3.1% 1.71 US$855
2004-01-23 2004-01-23 B Purchase PERRI ROSE C

COO, Acting CFO, Secretary

Executive Director Large shareholder
500 +0.2%
1.71
US$855 		500 +0.2% 1.71 US$855
Explore more

More insider trading research around Generex Biotechnology Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America